CIK 0001359931 · Non-accelerated filer<br>Smaller reporting company
Protara Therapeutics, Inc.
Sign in to watch- Ticker
- TARA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 204580525
- Phone
- 646-844-0337
- Business address
- 345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
- Former names
- Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-26 | Fry Hannah VP, Controller | Shares withheld for taxes | −1,457 | $6.67 | $10K | 42,723 |
| 2026-01-26 | Fabbio Patrick Chief Financial Officer | Shares withheld for taxes | −3,261 | $6.67 | $22K | 64,115 |
| 2026-01-20 | Shefferman Jesse CEO and President | Shares withheld for taxes | −16,322 | $5.60 | $91K | 1,030,564 |
| 2026-01-20 | Fabbio Patrick Chief Financial Officer | Shares withheld for taxes | −3,063 | $5.60 | $17K | 67,376 |
| 2026-01-20 | Zummo Jacqueline Chf Scientific Operations Off | Shares withheld for taxes | −6,578 | $5.60 | $37K | 122,283 |
| 2026-01-20 | Fry Hannah VP, Controller | Shares withheld for taxes | −2,132 | $5.60 | $12K | 44,180 |
| 2026-01-16 | CONKLING WILLIAM Chief Commercial Officer | Grant or award | +26,000 | 76,000 | ||
| 2026-01-16 | CONKLING WILLIAM Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +158,000 | 158,000 | ||
| 2026-01-16 | Fabbio Patrick Chief Financial Officer | Grant or award | +28,000 | 70,439 | ||
| 2026-01-16 | Fabbio Patrick Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +175,000 | 175,000 | ||
| 2026-01-16 | Fry Hannah VP, Controller | Grant or award | +9,500 | 46,312 | ||
| 2026-01-16 | Fry Hannah VP, Controller | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2026-01-16 | Nicacio Leonardo Viana Chief Medical Officer | Grant or award | +26,000 | 78,181 | ||
| 2026-01-16 | Nicacio Leonardo Viana Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +158,000 | 158,000 | ||
| 2026-01-16 | Shefferman Jesse CEO and President | Grant or award | +87,000 | 1,046,886 | ||
| 2026-01-16 | Shefferman Jesse CEO and President | Grant or award · Stock Option (Right to Buy) | +524,000 | 524,000 | ||
| 2026-01-16 | Zummo Jacqueline Chf Scientific Operations Off | Grant or award | +30,000 | 128,861 | ||
| 2026-01-16 | Zummo Jacqueline Chf Scientific Operations Off | Grant or award · Stock Option (Right to Buy) | +180,000 | 180,000 | ||
| 2025-06-27 | Shefferman Jesse CEO and President | Gift | −10,200 | 963,253 | ||
| 2025-06-27 | Shefferman Jesse CEO and President | Gift | −3,367 | 959,886 |
Page 2 of 8 · 154 trades